Correlation Between Evoke Pharma and Taysha Gene

Can any of the company-specific risk be diversified away by investing in both Evoke Pharma and Taysha Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Evoke Pharma and Taysha Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Evoke Pharma and Taysha Gene Therapies, you can compare the effects of market volatilities on Evoke Pharma and Taysha Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Evoke Pharma with a short position of Taysha Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Evoke Pharma and Taysha Gene.

Diversification Opportunities for Evoke Pharma and Taysha Gene

-0.41

Correlation Coefficient

Evoke Pharma  Taysha Gene

Very good diversification

The 3 months correlation between Evoke and Taysha is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and Taysha Gene Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Taysha Gene Therapies and Evoke Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Evoke Pharma are associated (or correlated) with Taysha Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Taysha Gene Therapies has no effect on the direction of Evoke Pharma i.e., Evoke Pharma and Taysha Gene go up and down completely randomly.

Pair Corralation between Evoke Pharma and Taysha Gene

Given the investment horizon of 90 days Evoke Pharma is expected to generate 0.75 times more return on investment than Taysha Gene. However, Evoke Pharma is 1.34 times less risky than Taysha Gene. It trades about -0.15 of its potential returns per unit of risk. Taysha Gene Therapies is currently generating about -0.22 per unit of risk. If you would invest  489.00  in Evoke Pharma on October 27, 2024 and sell it today you would lose (48.00) from holding Evoke Pharma or give up 9.82% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Evoke Pharma  vs.  Taysha Gene Therapies

Evoke Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Evoke Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Taysha Gene Therapies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Taysha Gene Therapies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong technical indicators, Taysha Gene is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Evoke Pharma and Taysha Gene

The main advantage of trading using opposite Evoke Pharma and Taysha Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Evoke Pharma position performs unexpectedly, Taysha Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Taysha Gene will offset losses from the drop in Taysha Gene's long position.

The idea behind Evoke Pharma and Taysha Gene Therapies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..